59 related articles for article (PubMed ID: 15641027)
1. Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma.
Rodriguez-Galindo C; Wofford M; Castleberry RP; Swanson GP; London WB; Fontanesi J; Pappo AS; Douglass EC
Cancer; 2005 Feb; 103(4):850-7. PubMed ID: 15641027
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival of a patient with leptomeningeal involvement by nasopharyngeal carcinoma after treatment with high-dose intravenous methotrexate.
Fakhry C; Bajaj G; Aygun N; Westra W; Gillison M
Head Neck; 2012 Feb; 34(2):296-300. PubMed ID: 20737501
[TBL] [Abstract][Full Text] [Related]
3. Treatment of nasopharyngeal carcinoma in children and adolescents: definitive results of a multicenter study (NPC-91-GPOH).
Mertens R; Granzen B; Lassay L; Bucsky P; Hundgen M; Stetter G; Heimann G; Weiss C; Hess CF; Gademann G
Cancer; 2005 Sep; 104(5):1083-9. PubMed ID: 15999363
[TBL] [Abstract][Full Text] [Related]
4. Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH/DCOG.
Buehrlen M; Zwaan CM; Granzen B; Lassay L; Deutz P; Vorwerk P; Staatz G; Gademann G; Christiansen H; Oldenburger F; Tamm M; Mertens R
Cancer; 2012 Oct; 118(19):4892-900. PubMed ID: 22359313
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel liposome, cisplatin and 5-fluorouracil-based induction chemotherapy followed by de-escalated intensity-modulated radiotherapy with concurrent cisplatin in stage IVA-IVB childhood nasopharyngeal carcinoma in endemic area: a phase II, single-arm trial.
Luo DH; Li XY; Guo SS; Guo WP; Liu LT; Mo HY; Guo L; Lv XF; Liu LZ; Li JB; Liu Q; Wang P; Sun XS; Liu SL; Chen QY; Tang LQ; Mai HQ
Lancet Reg Health West Pac; 2023 Nov; 40():100895. PubMed ID: 37691885
[TBL] [Abstract][Full Text] [Related]
6. Multimodal Treatment of Nasopharyngeal Carcinoma in Children, Adolescents and Young Adults-Extended Follow-Up of the NPC-2003-GPOH Study Cohort and Patients of the Interim Cohort.
Römer T; Franzen S; Kravets H; Farrag A; Makowska A; Christiansen H; Eble MJ; Timmermann B; Staatz G; Mottaghy FM; Bührlen M; Hagenah U; Puzik A; Driever PH; Greiner J; Jorch N; Tippelt S; Schneider DT; Kropshofer G; Overbeck TR; Christiansen H; Brozou T; Escherich G; Becker M; Friesenbichler W; Feuchtinger T; Puppe W; Heussen N; Hilgers RD; Kontny U
Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267570
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy Combined with PD-1 Inhibition Increases NK Cell Cytotoxicity towards Nasopharyngeal Carcinoma Cells.
Makowska A; Lelabi N; Nothbaum C; Shen L; Busson P; Tran TTB; Eble M; Kontny U
Cells; 2021 Sep; 10(9):. PubMed ID: 34572108
[TBL] [Abstract][Full Text] [Related]
8. Exploring the Optimal Chemotherapy Strategy for Locoregionally Advanced Children and Adolescent Nasopharyngeal Carcinoma Based on Pretreatment Epstein-Barr Virus DNA Level in the Era of Intensity Modulated Radiotherapy.
Zeng Z; Chen C; Guo L; Zhang C; Chen L; Yuan C; Lu L
Front Oncol; 2020; 10():600429. PubMed ID: 33489902
[TBL] [Abstract][Full Text] [Related]
9. Safety and Effectiveness of De-escalated Radiation Dose in T1-3 Nasopharyngeal Carcinoma: A Propensity Matched Analysis.
Wang X; Wang Y; Jiang S; Zhao J; Wang P; Zhang X; Wang F; Yin Z; Wang P
J Cancer; 2019; 10(21):5057-5064. PubMed ID: 31602257
[No Abstract] [Full Text] [Related]
10. Treatment of Childhood Nasopharyngeal Carcinoma With Induction Chemotherapy and Concurrent Chemoradiotherapy: Results of the Children's Oncology Group ARAR0331 Study.
Rodriguez-Galindo C; Krailo MD; Krasin MJ; Huang L; McCarville MB; Hicks J; Pashankar F; Pappo AS
J Clin Oncol; 2019 Dec; 37(35):3369-3376. PubMed ID: 31553639
[TBL] [Abstract][Full Text] [Related]
11. Update in pediatric nasopharyngeal undifferentiated carcinoma.
Claude L; Jouglar E; Duverge L; Orbach D
Br J Radiol; 2019 Oct; 92(1102):20190107. PubMed ID: 31322911
[TBL] [Abstract][Full Text] [Related]
12. Interferon beta increases NK cell cytotoxicity against tumor cells in patients with nasopharyngeal carcinoma via tumor necrosis factor apoptosis-inducing ligand.
Makowska A; Franzen S; Braunschweig T; Denecke B; Shen L; Baloche V; Busson P; Kontny U
Cancer Immunol Immunother; 2019 Aug; 68(8):1317-1329. PubMed ID: 31312900
[TBL] [Abstract][Full Text] [Related]
13. Interferon β and Anti-PD-1/PD-L1 Checkpoint Blockade Cooperate in NK Cell-Mediated Killing of Nasopharyngeal Carcinoma Cells.
Makowska A; Braunschweig T; Denecke B; Shen L; Baloche V; Busson P; Kontny U
Transl Oncol; 2019 Sep; 12(9):1237-1256. PubMed ID: 31295651
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide CRISPR-based gene knockout screens reveal cellular factors and pathways essential for nasopharyngeal carcinoma.
Wang C; Jiang S; Ke L; Zhang L; Li D; Liang J; Narita Y; Hou I; Chen CH; Wang L; Zhong Q; Ling Y; Lv X; Xiang Y; Guo X; Teng M; Tsao SW; Gewurz BE; Zeng MS; Zhao B
J Biol Chem; 2019 Jun; 294(25):9734-9745. PubMed ID: 31073033
[TBL] [Abstract][Full Text] [Related]
15. Adapted strategy to tumor response in childhood nasopharyngeal carcinoma: the French experience.
Jouin A; Helfre S; Bolle S; Claude L; Laprie A; Bogart E; Vigneron C; Potet H; Ducassou A; Claren A; Riet FG; Castex MP; Faure-Conter C; Fresneau B; Defachelles AS; Orbach D
Strahlenther Onkol; 2019 Jun; 195(6):504-516. PubMed ID: 30963203
[TBL] [Abstract][Full Text] [Related]
16. Salvage regimens for pediatric patients with relapsed nasopharyngeal carcinoma.
DeRenzo C; Lam C; Rodriguez-Galindo C; Rapkin L; Gottschalk S; Venkatramani R
Pediatr Blood Cancer; 2019 Jan; 66(1):e27469. PubMed ID: 30318742
[TBL] [Abstract][Full Text] [Related]
17. Interferon beta induces apoptosis in nasopharyngeal carcinoma cells
Makowska A; Wahab L; Braunschweig T; Kapetanakis NI; Vokuhl C; Denecke B; Shen L; Busson P; Kontny U
Oncotarget; 2018 Mar; 9(18):14228-14250. PubMed ID: 29581840
[TBL] [Abstract][Full Text] [Related]
18. Induction Chemotherapy Plus Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma in Children and Adolescents: A Matched Cohort Analysis.
Li Y; Tang LQ; Liu LT; Guo SS; Liang YJ; Sun XS; Tang QN; Bei JX; Tan J; Chen S; Ma J; Zhao C; Chen QY; Mai HQ
Cancer Res Treat; 2018 Oct; 50(4):1304-1315. PubMed ID: 29334605
[TBL] [Abstract][Full Text] [Related]
19. Chloroquine Sensitizes Nasopharyngeal Carcinoma Cells but Not Nasoepithelial Cells to Irradiation by Blocking Autophagy.
Makowska A; Eble M; Prescher K; Hoß M; Kontny U
PLoS One; 2016; 11(11):e0166766. PubMed ID: 27902742
[TBL] [Abstract][Full Text] [Related]
20. Pediatric Nasopharyngeal Cancer: Case Report and Review of the Literature.
González-Motta A; González G; Bermudéz Y; Maldonado MC; Castañeda JM; Lopéz D; Cotes-Mestre M
Cureus; 2016 Feb; 8(2):e497. PubMed ID: 27014531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
